Dr. Hatem Eleishi Rheumatologist
@drhatemeleishirheumatologist • Joined November 26, 2020
At a glance
Subscribers
Last 25 days3.47K
Views
Last 25 days288K
Videos
Last 25 days118
Charts
Subscribers, views & videos over time
Subscribers gained (weekly) · 6 mo
Views gained (weekly) · 6 mo
Subs milestone changes (up to 30)
Views milestone changes (up to 30)
Engagement
Avg. views per video
2.44K
Total views ÷ total videos
Views per subscriber
83×
Total views ÷ subscribers
Subs per video
29
Subscribers ÷ total videos
Revenue estimate
Details →Total (all-time): $202 – $578
Daily avg.: $0 – $0
Weekly avg.: $1 – $2
Last 25 days: $3 – $8
Based on estimated $0.7–$2 CPM.
Analytics tables
Analytics Table:Dr. Hatem Eleishi Rheumatologist
| Date | subscribers | views | videos |
|---|---|---|---|
Jun 1, 2026 Jun 1 Mon | 3.47K +10 | 288K +804 | 118 +2 |
May 25, 2026 May 25 Mon | 3.46K +10 | 287K +1.18K | 116 +2 |
May 18, 2026 May 18 Mon | 3.45K +10 | 286K +1.11K | 114 +2 |
May 11, 2026 May 11 Mon | 3.44K +20 | 285K +3.61K | 112 +5 |
Apr 27, 2026 Apr 27 Mon | 3.42K -- | 281K -- | 107 -- |
Subscribers gained (weekly)
| Week | Subscribers gained | Change vs prev |
|---|---|---|
May 11, 2026 | 20 | +20 |
May 18, 2026 | 10 | -10 |
May 25, 2026 | 10 | -- |
Jun 1, 2026 | 10 | -- |
Views gained (weekly)
| Week | Views gained | Change vs prev |
|---|---|---|
May 11, 2026 | 3.61K | +3.61K |
May 18, 2026 | 1.11K | -2.49K |
May 25, 2026 | 1.18K | +71 |
Jun 1, 2026 | 804 | -381 |
About
This channel targets English-speaking patients who have arthritis, in particular autoimmune arthritis diseases like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Still's disease, palindromic rheumatism, polymyalgia rheumatica and many more other disorders. Dr. Hatem Eleishi regularly publishes vide…
- Joined
- November 26, 2020
More features coming
We're working on new analytics and tools. Stay tuned.
Growth Rankings
Egypt · Education
Subs gained
#3,547
Views gained
#4,372
Categories
More features coming
We're working on new analytics and tools. Stay tuned.